Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy
about
Osteopontin is expressed in the mouse uterus during early pregnancy and promotes mouse blastocyst attachment and invasion in vitroAsynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy.Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx miceMatricellular proteins in cardiac adaptation and disease.Dysregulated mechanisms underlying Duchenne muscular dystrophy from co-expression network preservation analysisDeletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient miceAge dependent increase in the levels of osteopontin inhibits skeletal muscle regeneration.Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases.Selective Expression of Osteopontin in ALS-resistant Motor Neurons is a Critical Determinant of Late Phase Neurodegeneration Mediated by Matrix Metalloproteinase-9.Initial pulmonary respiration causes massive diaphragm damage and hyper-CKemia in Duchenne muscular dystrophy dog.Featured article: induction of heme oxygenase with hemin improves pericardial adipocyte morphology and function in obese Zucker rats by enhancing proteins of regeneration.Wasting mechanisms in muscular dystrophy.Particularly interesting Cys-His-rich protein is highly expressed in human intracranial aneurysms and resists aneurysmal rupture.Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway.The physiological response of protease inhibition in dystrophic muscle.Treatment of dystrophin cardiomyopathies.Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy.Pathoproteomic profiling of the skeletal muscle matrisome in dystrophinopathy associated myofibrosis.Osteopontin stimulates matrix metalloproteinase expression through the nuclear factor-κB signaling pathway in rat temporomandibular joint and condylar chondrocytes.Serum osteopontin, but not OPN gene polymorphism, is associated with LVH in essential hypertensive patients.Suramin attenuates dystrophin-deficient cardiomyopathy in the mdx mouse model of duchenne muscular dystrophy.Clinical and in vitro analysis of Osteopontin as a prognostic indicator and unveil its potential downstream targets in bladder cancer.Dystrophic Cardiomyopathy: Complex Pathobiological Processes to Generate Clinical Phenotype.Immunological blockade of adipocyte inflammation caused by increased matrix metalloproteinase-cleaved osteopontin in obesity.Defective Flux of Thrombospondin-4 through the Secretory Pathway Impairs Cardiomyocyte Membrane Stability and Causes Cardiomyopathy
P2860
Q34061848-F6C8D6DF-7B80-4F0F-9076-294B545993F6Q34332718-8A43C655-AC8A-497B-82E4-10702F7F49BAQ34973330-176DB945-0889-4437-BBE5-71000E9CF067Q35542423-AEFEE022-329B-44BE-A6DE-332531B87019Q35583817-A81E6DD6-FBF5-4157-9E61-83146DE29EA5Q36167600-7E21341F-7E79-4D63-B5DF-697C7556AC8FQ36288658-D15252E0-EBDF-4AC8-86BF-2623BC85912CQ36356925-2FE1AD0B-9528-41B4-B29F-57312A3FCE91Q36970239-2BCF0187-310E-4DD1-A584-7A8E03A8667AQ37011450-557A5B1C-F52F-4BB8-8859-B94E8FA1123BQ37070966-753DF71B-C5C2-4672-B943-94377D8DDAECQ37138490-C3351154-2900-41AD-AC70-970BF484023BQ37581757-D28777E2-B4E8-469E-82EA-CF40B9057537Q37705799-11252D9C-5985-40C1-85E8-9E0688F11BFBQ38104503-C4062E51-26CA-4305-AA77-B716E30D7261Q38178061-DA7CF144-455A-4A53-8B58-5BC15B34172BQ38264461-E869F5B0-731A-45BE-B93E-EEF1E97A5E8CQ38563300-E97FCBE5-9B63-44D0-A3FE-EAA3ECCD58DEQ42068316-843B6FB5-2B72-4BE7-9F04-7CF9F55FC0FBQ45716394-84BD9E98-872B-4ECA-B80C-7E446284F065Q45953214-A4B520A1-56E9-47A0-A540-AF6412F5E95FQ47131436-04D8CCDA-05D2-4950-B5B9-84C716FAD9A8Q49428049-CCFB2A1B-BBC5-4742-8B2A-C63281EDC8C1Q52958600-DEA4FE1B-A5CA-44EC-8A24-CD76E20C2CACQ57396440-D137A7F1-3D18-47C6-815F-F0E068C02D35
P2860
Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Osteopontin-stimulated express ...... of Duchenne muscular dystrophy
@ast
Osteopontin-stimulated express ...... of Duchenne muscular dystrophy
@en
type
label
Osteopontin-stimulated express ...... of Duchenne muscular dystrophy
@ast
Osteopontin-stimulated express ...... of Duchenne muscular dystrophy
@en
prefLabel
Osteopontin-stimulated express ...... of Duchenne muscular dystrophy
@ast
Osteopontin-stimulated express ...... of Duchenne muscular dystrophy
@en
P2093
P2860
P356
P1476
Osteopontin-stimulated express ...... of Duchenne muscular dystrophy
@en
P2093
Ashok Kumar
Natia Qipshidze
Saurabh Dahiya
Shephali Bhatnagar
Srikanth Givvimani
Suresh C Tyagi
P2860
P304
P356
10.4049/JIMMUNOL.1101342
P407
P577
2011-08-01T00:00:00Z